Who
Camilla Simpson V
Director
Company insider
Files Form 4 as: Director, Spruce Biosciences; Director, GRI Bio.
In numbers
- Trades disclosed
- 28
- Buys
- 0
- Sells
- 2
- Bought
- $0
- Sold
- $232K
- Companies
- 2
- Companies where not an officer
- 2
- First trade
- 30 Apr 2021
- Last trade
- 21 May 2026
- Last filed
- 26 May 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 21 May 2026filed 26 May 2026 | SPRB Spruce Biosciencesoption or derivative · Biotechnology | SEC FORM 4 Code A | —1,700 at $0.00 | filing |
| 21 May 2026filed 26 May 2026 | SPRB Spruce Biosciencesoption or derivative · Biotechnology | SEC FORM 4 Code A | —1,700 at $0.00 | filing |
| 11 Dec 2025filed 15 Dec 2025 | SPRB Spruce Biosciencesoption or derivative · Biotechnology | SEC FORM 4 Code A | —173 | filing |
| 11 Dec 2025filed 15 Dec 2025 | SPRB Spruce Biosciencesoption or derivative · Biotechnology | SEC FORM 4 Code D | —173 | filing |
| 11 Dec 2025filed 15 Dec 2025 | SPRB Spruce Biosciencesoption or derivative · Biotechnology | SEC FORM 4 Code A | —309 | filing |
| 11 Dec 2025filed 15 Dec 2025 | SPRB Spruce Biosciencesoption or derivative · Biotechnology | SEC FORM 4 Code D | —309 | filing |
| 11 Dec 2025filed 15 Dec 2025 | SPRB Spruce Biosciencesoption or derivative · Biotechnology | SEC FORM 4 Code A | —362 | filing |
| 11 Dec 2025filed 15 Dec 2025 | SPRB Spruce Biosciencesoption or derivative · Biotechnology | SEC FORM 4 Code D | —362 | filing |
| 11 Dec 2025filed 15 Dec 2025 | SPRB Spruce Biosciencesoption or derivative · Biotechnology | SEC FORM 4 Code A | —133 | filing |
| 11 Dec 2025filed 15 Dec 2025 | SPRB Spruce Biosciencesoption or derivative · Biotechnology | SEC FORM 4 Code D | —133 | filing |
| 11 Dec 2025filed 15 Dec 2025 | SPRB Spruce Biosciencesoption or derivative · Biotechnology | SEC FORM 4 Code A | —400 | filing |
| 11 Dec 2025filed 15 Dec 2025 | SPRB Spruce Biosciencesoption or derivative · Biotechnology | SEC FORM 4 Code D | —400 | filing |
| 18 Sep 2025filed 22 Sep 2025 | GRI GRI Biooption or derivative · Biotechnology | SEC FORM 4 Code A | —23,605 at $0.00 | filing |
| 26 Aug 2025filed 27 Aug 2025 | GRI GRI Biooption or derivative · Biotechnology | SEC FORM 4 Code A | —5,994 at $0.00 | filing |
| 13 Aug 2025filed 14 Aug 2025 | GRI GRI Biooption or derivative · Biotechnology | SEC FORM 4 Code A | —4,527 at $0.00 | filing |
| 22 Jul 2025filed 24 Jul 2025 | SPRB Spruce Biosciencesoption or derivative · Biotechnology | SEC FORM 4 Code A | —30,000 at $0.00 | filing |
| 23 Jan 2025filed 24 Jan 2025 | GRI GRI Biooption or derivative · Biotechnology | SEC FORM 4 Code A | $21K30,297 at $0.69 | filing |
| 22 May 2024filed 24 May 2024 | SPRB Spruce Biosciencesoption or derivative · Biotechnology | SEC FORM 4 Code A | —30,000 at $0.00 | filing |
| 10 Aug 2023filed 14 Aug 2023 | GRI GRI Biooption or derivative · Biotechnology | SEC FORM 4 Code A | $100K34,483 at $2.90 | filing |
| 25 May 2023filed 26 May 2023 | SPRB Spruce Biosciencesoption or derivative · Biotechnology | SEC FORM 4 Code A | —30,000 at $0.00 | filing |
News
Spruce Biosciences Announces Presentation of MPS IIIB Natural History Data at the 55th Child Neurology Society Annual MeetingSPRB · stratfordbeaconherald.com · 8 Oct 2026
0 headlines in the last 90 days name Camilla Simpson V; 1 article from the last 14 days about the 1 company they traded most, at most three about any one of them.